No-Reflow: A Heterogeneous Clinical Phenomenon with Multiple Therapeutic Strategies

By  

Current Pharmaceutical Design, Vol. 12, Iss. 29, 2006-10 ,pp. : 3807-3815

Bentham Science Publishers

Access to resources Recommend Favorite

Modulation of Individual Susceptibility to the No-Reflow Phenomenon after Acute Myocardial Infarction

By  

Current Pharmaceutical Design, Vol. 19, Iss. 25, 2013-08 ,pp. : 4519-4528

Bentham Science Publishers

Access to resources Recommend Favorite

The Effect of Statins on the No-Reflow Phenomenon: An Observational Study in Patients with Hyperglycemia before Primary Angioplasty

By Zhao Jing-Lin   Yang Yue-Jin   Pei Wei-Dong   Sun Yu-Hua   Chen Ji-Lin  

American Journal of Cardiovascular Drugs, Vol. 9, Iss. 2, 2009-01 ,pp. : 81-89

Adis International

Access to resources Recommend Favorite

Detection of Gram-Negative &bgr;-Lactamase Producing Pathogens in the Clinical Lab

By  

Current Pharmaceutical Design, Vol. 19, Iss. 2, 2013-01 ,pp. : 250-256

Bentham Science Publishers

Access to resources Recommend Favorite

The Effect of Detection Approaches on the Reported Incidence of Tenfold Errors

By Kozer Eran   Scolnik Dennis   Jarvis Anna D.   Koren Gideon  

Drug Safety, Vol. 29, Iss. 2, 2006-01 ,pp. : 169-174

Adis International

Access to resources Recommend Favorite